Maleimide-PEG8-Val-Ala-PAB
Maleimide-PEG8-Val-Ala-PAB is an ADC linker composed of the cleavable Val-Ala-PAB linker and the probe molecule Maleimide (HY-W007324). Maleimide-PEG8-Val-Ala-PAB can be used to connect Cetuximab (HY-P9905) monoclonal antibody and CDK inhibitor SNS-032 (HY-10008) to synthesize antibody-drug conjugates (ADCs).
Product Specifications
UNSPSC
12352005
Target
ADC Linker
Type
Reference compound
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/maleimide-peg8-val-ala-pab.html
Smiles
O=C(NCCOCCOCCOCCOCCOCCOCCOCCOCCC(N[C@H](C(N[C@@H](C)C(NC1=CC=C(CO)C=C1)=O)=O)C(C)C)=O)CCN2C(C=CC2=O)=O
Molecular Formula
C41H65N5O15
Molecular Weight
867.98
References & Citations
[1]Cheung A, Chenoweth A M, Johansson A, et al. Anti-EGFR antibody-drug conjugate carrying an inhibitor targeting CDK restricts triple-negative breast cancer growth[J]. Clinical Cancer Research, 2024.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040633-100 1x 100 µL
Von Willebrand Factor (3E2D10), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880906-100 1x 100 µL
Cytokeratin 7 (KRT7/760 + KRT7/903), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details